We believe immunotherapy is the best path to a cure for brain tumor patients. Our research is driven by a deep understanding of the tumor microenvironment, with a special focus on the states of myeloid cells within tumors. We concentrate on understanding how these cells hinder the effectiveness of immunotherapies and explore strategies to transform their function to enhance the efficacy of these treatments.
Video Presentation at the Myeloid Network on our approaches.
